Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid dosage regimens on blood loss in hemi-mandibulectomy
PACTR202110492542153Phase 4Completed
- Sponsor
- Dr. Okoro Ndidi
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tranexamic acid in Maxillofacial Disorders (3 arms), sponsored by Dr. Okoro Ndidi. Primary endpoint: Amount of blood loss. Started Jan 2019; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Maxillofacial Disorders
Beyond the preview
Go deeper on PACTR202110492542153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202110492542153.